XPD Asp312Asn polymorphism is a risk factor for prostate cancer

Journal of Cancer Research & Clinical Oncology, 06/04/2012

The results of this meta–analysis indicate that the Xeroderma pigmentosum Group D (XPD) Asp312Asn polymorphism is a risk factor for prostate cancer development.

Print Article Summary